Medtronic began the U.S. rollout on Tuesday of its latest insulin pump system paired with a glucose sensor made by Abbott. The partnership marks a new foray for Medtronic, which has typically paired its insulin pumps and pens with its own continuous glucose monitors in the past.
Abbott and Medtronic announced the partnership last year, with Abbott developing a new glucose sensor exclusively for Medtronic. The sensor, called Instinct, has a 15-day wear time, longer than any of Medtronic’s current CGMs.
In September, Medtronic received an expanded label from the Food and Drug Administration for its MiniMed 780G system, designating Medtronic’s algorithm as an interoperable automated glycemic controller, which allows it to be paired with CGMs made by other companies.
Medtronic continues to develop its own sensors. The company is also working on a new, smaller form-factor pump called MiniMed Flex that it plans to integrate with the Instinct CGM, Que Dallara, the leader of Medtronic’s diabetes business, told MedTech Dive in September.
